Hospital
Maryland General Hospital INC
Maryland General Hospital INC was paid $3.33M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 37% of everything it billed.
33Billing provider infoMARYLAND GENERAL HOSPITAL INC
BALTIMORE, MD 21201
BALTIMORE, MD 21201
33aNPI1669565180assigned 10/02/2006
33bProvider typeChronic Disease Hospital
28Total paid$3.33M
24GClaims115,487
24DCodes billed100
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SPRINKEL, GEORGE controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,248 | $191K | |
| 2019 | 24,847 | $451K | |
| 2020 | 12,620 | $592K | |
| 2021 | 16,924 | $607K | |
| 2022 | 14,820 | $534K | |
| 2023 | 13,123 | $554K | |
| 2024incomplete | 8,905 | $404K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 37% | 30,815 | 25,678 | $1.23M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 4,783 | 4,324 | $705K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 3,673 | 2,987 | $317K |
| G0378 | Hospital observation service, per hour | 6.6% | 657 | 581 | $221K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 1,054 | 985 | $202K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 5.2% | 5,894 | 4,520 | $174K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.4% | 2,633 | 1,822 | $113K |
| 29581 | 2.3% | 745 | 225 | $76K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.6% | 34 | 13 | $53K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1.1% | 244 | 229 | $38K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 38 | 26 | $31K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 46 | 40 | $25K |
88 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 518 | $23K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 674 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 349 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 849 | $11K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 604 | $9K |
| 97597 | <1% | 76 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,594 | $8K |
| 92083 | <1% | 27 | $6K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 16 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,237 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 708 | $4K |
| 84484 | <1% | 1,889 | $3K | |
| 90750 | <1% | 43 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 191 | $3K |
| 84100 | <1% | 2,782 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,905 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 448 | $2K |
| 90662 | <1% | 119 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,714 | $2K |
| 92133 | <1% | 76 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,335 | $2K |
| 97161 | <1% | 97 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 470 | $2K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 70 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 782 | $2K |
| 92134 | <1% | 36 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 5,366 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 126 | $782.31 |
| 90694 | <1% | 87 | $716.96 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,920 | $657.72 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 590 | $625.09 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 997 | $544.52 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,531 | $541.06 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 66 | $531.65 |
| 90732 | <1% | 13 | $445.32 | |
| 83735 | <1% | 4,070 | $293.60 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,828 | $243.21 |
| 81003 | <1% | 163 | $200.07 | |
| 90686 | <1% | 517 | $176.69 | |
| 83690 | <1% | 1,559 | $166.37 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,867 | $154.00 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,087 | $137.16 |
| 81001 | <1% | 2,586 | $131.11 | |
| 71045 | Radiologic examination, chest; single view | <1% | 888 | $128.94 |
| 84703 | <1% | 86 | $117.32 | |
| 85730 | <1% | 1,016 | $114.21 | |
| 85027 | <1% | 1,460 | $113.98 | |
| 85610 | <1% | 1,617 | $112.52 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,269 | $92.67 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,719 | $87.67 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 459 | $83.85 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,409 | $76.71 |
| 86850 | <1% | 42 | $66.39 | |
| 80061 | Lipid panel | <1% | 78 | $55.90 |
| 83605 | <1% | 299 | $23.74 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 442 | $20.92 |
| 86901 | <1% | 42 | $20.72 | |
| 86900 | <1% | 42 | $20.72 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 131 | $14.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 330 | $5.82 |
| 94760 | 0% | 206 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 74 | $0.00 |
| 83880 | 0% | 101 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 42 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 0% | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 64 | $0.00 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 166 | $0.00 |
| 82043 | 0% | 38 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 182 | $0.00 |
| 90480 | 0% | 135 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 16 | $0.00 |
| 90656 | 0% | 15 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 12 | $0.00 |
| 86803 | 0% | 12 | $0.00 | |
| 84439 | 0% | 240 | $0.00 | |
| 71250 | 0% | 17 | $0.00 | |
| 91320 | 0% | 135 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 448 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 126 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 139 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 77 | $0.00 |
| 82570 | 0% | 89 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 26 | $0.00 |
| 94726 | 0% | 13 | $0.00 | |
| 94729 | 0% | 12 | $0.00 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 93 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 35 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPRINKEL, GEORGE (SR VP AND CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| University of Maryland Medical Center, LLC | Baltimore, MD | $18.03M |
| University of Maryland Medical Center, LLC | Baltimore, MD | $16.54M |
| University of Maryland Medical Center, LLC | Baltimore, MD | $10.19M |
| University of Maryland Medical Center, LLC | Baltimore, MD | $9.24M |
| Maryland General Hospital, INC. | Baltimore, MD | $7.12M |
| University of Maryland Midtown Health INC | Baltimore, MD | $3.15M |
| Maryland General Clinical Practice Group, INC. | Baltimore, MD | $1.38M |
| University of Maryland Medical Center, LLC | Baltimore, MD | $1.07M |
| University of Maryland Medical Center, LLC | Linthicum, MD | $804K |
| Maryland General Hospital, INC. | Baltimore, MD | $524K |
| Maryland General Clinical Practice Group, INC. | Baltimore, MD | $395K |
| University of Maryland Medical Center, LLC | Baltimore, MD | $210K |
| University of Maryland Medical Center, LLC | Baltimore, MD | $193K |
| University of Maryland Medical Center, LLC | Baltimore, MD | $59K |
| University of Maryland Medical Center, LLC | Baltimore, MD | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.